ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 50 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2017. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,568 | +156.8% | 1,102 | +78.0% | 0.00% | – |
Q3 2022 | $1,000 | – | 619 | +61800.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q4 2021 | $44,000 | -83.2% | 11,271 | -87.0% | 0.00% | – |
Q2 2021 | $262,000 | -25.1% | 86,771 | -17.5% | 0.00% | – |
Q1 2021 | $350,000 | +414.7% | 105,166 | +449.1% | 0.00% | – |
Q4 2020 | $68,000 | -68.9% | 19,151 | -91.2% | 0.00% | – |
Q1 2020 | $219,000 | -45.7% | 216,708 | +49.2% | 0.00% | – |
Q4 2019 | $403,000 | +379.8% | 145,210 | +1169.8% | 0.00% | – |
Q2 2018 | $84,000 | -92.3% | 11,436 | -93.5% | 0.00% | -100.0% |
Q3 2017 | $1,092,000 | +72.2% | 176,091 | +0.1% | 0.00% | 0.0% |
Q2 2017 | $634,000 | +10.8% | 176,000 | -0.0% | 0.00% | 0.0% |
Q1 2017 | $572,000 | +32.7% | 176,001 | -0.0% | 0.00% | – |
Q4 2016 | $431,000 | -29.3% | 176,080 | -0.7% | 0.00% | -100.0% |
Q3 2016 | $610,000 | -0.5% | 177,260 | +0.6% | 0.00% | 0.0% |
Q2 2016 | $613,000 | -15.7% | 176,270 | +0.1% | 0.00% | 0.0% |
Q1 2016 | $727,000 | -7.4% | 176,150 | -0.0% | 0.00% | 0.0% |
Q4 2015 | $785,000 | -29.1% | 176,231 | -3.0% | 0.00% | 0.0% |
Q3 2015 | $1,107,000 | – | 181,652 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 3,705,128 | $10,300,000 | 4.44% |
RTW INVESTMENTS, LP | 5,666,754 | $15,754,000 | 0.59% |
COWEN AND COMPANY, LLC | 926,200 | $2,575,000 | 0.22% |
Hudson Bay Capital Management LP | 850,000 | $2,363,000 | 0.05% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,774,915 | $4,934,000 | 0.03% |
Point72 Asset Management, L.P. | 1,897,284 | $5,274,000 | 0.03% |
683 Capital Management, LLC | 77,368 | $215,000 | 0.02% |
Secure Asset Management, LLC | 10,000 | $28,000 | 0.02% |
Qube Research & Technologies Ltd | 166,138 | $462,000 | 0.01% |
Verition Fund Management LLC | 174,455 | $485,000 | 0.01% |